Related Experiment Video
Updated: Sep 19, 2025
08:29
Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
10.2K
Design and Evaluation of Biodegradable Self-Immolative Lipids for RNA Delivery
Rajesh Mukthavaram1, Amit Sagi1, Hyojung Hong1
1Arcturus Therapeutics, 10628 Science Center Drive, Suite 250, San Diego, CA, 92121, USA.
Advanced Healthcare Materials
|June 16, 2025
Summary
Researchers developed novel Self-Immolative Lipids (SILs) for nucleic acid delivery. These lipids offer enhanced biodegradability and stability, improving upon existing lipid nanoparticle technology for gene therapy applications.
Area of Science:
- Biochemistry
- Nanotechnology
- Pharmacology
Background:
- Lipid nanoparticles (LNPs) are established platforms for nucleic acid therapeutics, as evidenced by approved treatments like Patisiran and COVID-19 mRNA vaccines.
- Safe and effective LNP delivery systems require rapid degradation and clearance of lipid components post-administration.
- Current non-viral gene therapy vectors face challenges in balancing stability during circulation with efficient biodegradability within target cells.
Purpose of the Study:
- To introduce a new class of ionizable cationic lipids, termed Self-Immolative Lipids (SILs).
- To design a lipid architecture that ensures stability during biodistribution and promotes degradation upon cellular uptake.
- To evaluate the performance of SILs as a delivery system for nucleic acid-based therapeutics.
Main Methods:
- Synthesis and characterization of a novel family of Self-Immolative Lipids (SILs).
- Assessment of lipid stability in serum conditions.
- Evaluation of biodegradability under reducing cytosolic conditions via disulfide reduction and self-elimination pathways.
- Comparative analysis of SILs' efficacy and biodegradability against MC3, a benchmark ionizable lipid.
Main Results:
- SILs exhibit high stability in serum, crucial for effective cargo delivery.
- SILs demonstrate efficient biodegradation in the cytosol through a disulfide reduction and self-elimination mechanism.
- The novel SILs showed improved or equivalent therapeutic activity compared to MC3.
- SILs exhibited enhanced biodegradability relative to the lipid currently used in Patisiran.
Conclusions:
- Self-Immolative Lipids (SILs) represent a promising advancement in LNP technology for gene therapy.
- The designed SILs overcome the stability-biodegradability trade-off, offering a safer and potentially more effective delivery system.
- This new lipid platform facilitates complete degradation for efficient elimination, addressing a key challenge in non-viral gene delivery.
